Alex Osei-Akoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alex Osei-Akoto has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Ansong
Kumasi Ashanti Region Kwame Nkrumah University of Science and Technology
6 shared publications Samuel Blay Nguah
3 shared publicationsVivian Paintsil
Komfo Anokye Teaching Hospital, Kumasi, Ghana
3 shared publicationsDaniel Ansong
2 shared publicationsDavid Sambian
2 shared publications- Fareed Kow Nanse Arthur
Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi 00233, Ghana
2 shared publications
Latest Publications
- 5 July 2019
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (7) , e391-e395
Decreased Mortality After Establishing a Pediatric Emergency Unit at an Urban Referral Hospital in Ghana
Emergently ill infants and children are often inadequately recognized and stabilized by health care facilities in low- and middle-income countries. Limited reports have shown that process improvements and prioritization of emergency care for children presenting to the hospital can improve pediatric hospital mortality. A dedicated pediatric emergency unit (PEU) was established for nontrauma emergencies at a busy teaching and referral hospital in Kumasi, Ghana, in response to high inpatient mortality early during hospitalization. The PEU was designed to identify and separate critically ill children from more stable children on admission. Locally available hospital resources were reallocated from other areas of the hospital to prioritize staffing and supplies for the PEU. A multiyear data set of nonnewborn inpatient mortality was analyzed with a change point model to find the point at which mortality changed the most within the Department of Child Health or the maximum likelihood estimate. Relative risk of mortality for the periods 1 and 2 years immediately before and after the implementation of the PEU and each individual year compared with its preceding year was analyzed to further establish a temporal correlation of changes in mortality rates to the PEU implementation. Individual years were also analyzed against preimplementation data to establish the durability of mortality improvements. Patient mortality decreased over the analyzed period with the maximum change point strongly associated with implementation of the PEU. Relative risk values of mortality 1 year and 2 years immediately before and after implementation of the PEU were 0.70 (0.62–0.78) and 0.69 (0.64–0.74) respectively, representing a one-third reduction in mortality. The only other mortality improvements seen in the year-to-year analysis were between July 2004–June 2005 compared with July 2005–June 2006 with a relative risk of 0.86 (0.77–0.96). Prioritizing and redirecting limited resources toward pediatric emergency care in low- and middle-income country hospitals is associated with reductions in inpatient mortality that are both immediate and sustained.
- 5 July 2019
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (7) , e391-e395
Decreased Mortality After Establishing a Pediatric Emergency Unit at an Urban Referral Hospital in Ghana
Emergently ill infants and children are often inadequately recognized and stabilized by health care facilities in low- and middle-income countries. Limited reports have shown that process improvements and prioritization of emergency care for children presenting to the hospital can improve pediatric hospital mortality. A dedicated pediatric emergency unit (PEU) was established for nontrauma emergencies at a busy teaching and referral hospital in Kumasi, Ghana, in response to high inpatient mortality early during hospitalization. The PEU was designed to identify and separate critically ill children from more stable children on admission. Locally available hospital resources were reallocated from other areas of the hospital to prioritize staffing and supplies for the PEU. A multiyear data set of nonnewborn inpatient mortality was analyzed with a change point model to find the point at which mortality changed the most within the Department of Child Health or the maximum likelihood estimate. Relative risk of mortality for the periods 1 and 2 years immediately before and after the implementation of the PEU and each individual year compared with its preceding year was analyzed to further establish a temporal correlation of changes in mortality rates to the PEU implementation. Individual years were also analyzed against preimplementation data to establish the durability of mortality improvements. Patient mortality decreased over the analyzed period with the maximum change point strongly associated with implementation of the PEU. Relative risk values of mortality 1 year and 2 years immediately before and after implementation of the PEU were 0.70 (0.62–0.78) and 0.69 (0.64–0.74) respectively, representing a one-third reduction in mortality. The only other mortality improvements seen in the year-to-year analysis were between July 2004–June 2005 compared with July 2005–June 2006 with a relative risk of 0.86 (0.77–0.96). Prioritizing and redirecting limited resources toward pediatric emergency care in low- and middle-income country hospitals is associated with reductions in inpatient mortality that are both immediate and sustained.
- 13 February 2019
- Published by Wiley in Transfusion
- Vol. 59 (6) , 2016-2022
Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease
BACKGROUND: The routine pretransfusion investigations in Southern Ghana involve only ABO‐D blood group typing and ABO compatibility testing without screening for irregular red blood cell (RBC) antibodies. The prevalence and specificities of RBC antibodies and frequencies of most minor blood group antigens in transfused patients with sickle cell disease (SCD) in Ghana are not known and are the objectives of this study.STUDY DESIGN AND METHODS: This was a cross‐sectional study that investigated transfused patients with SCD for the presence of irregular RBC antibodies and Rhesus, Kell, Duffy, Kidd, and Ss antigens.RESULTS: From a total of 154 patients (median age, 9 years), 10 patients (6.5%) possessed 13 antibodies, predominantly against D, C, and E antigens. In three patients, the antibodies (anti‐D, anti‐D + C, and anti‐C + e) were against antigens they possessed by serology. Genotyping showed that two of these patients had variant RHCE genes that encode for weak and partial e antigens and one patient had a partial RHC gene. Frequencies of most RBC antigens were comparable with frequencies established among the African American population; however, K–k– and Jk(a–b–) phenotypes were more frequent and were present in 21% and 17% of patients, respectively.CONCLUSION: The prevalence of RBC alloimmunization in transfused Ghanaian patients with SCD was 6.5% and the majority of antibodies were against antigens of the Rh system. Our findings stress the need to include pretransfusion testing for RBC antibodies in patients with SCD, to improve transfusion safety.
- 13 February 2019
- Published by Wiley in Transfusion
- Vol. 59 (6) , 2016-2022
Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease
BACKGROUND: The routine pretransfusion investigations in Southern Ghana involve only ABO‐D blood group typing and ABO compatibility testing without screening for irregular red blood cell (RBC) antibodies. The prevalence and specificities of RBC antibodies and frequencies of most minor blood group antigens in transfused patients with sickle cell disease (SCD) in Ghana are not known and are the objectives of this study.STUDY DESIGN AND METHODS: This was a cross‐sectional study that investigated transfused patients with SCD for the presence of irregular RBC antibodies and Rhesus, Kell, Duffy, Kidd, and Ss antigens.RESULTS: From a total of 154 patients (median age, 9 years), 10 patients (6.5%) possessed 13 antibodies, predominantly against D, C, and E antigens. In three patients, the antibodies (anti‐D, anti‐D + C, and anti‐C + e) were against antigens they possessed by serology. Genotyping showed that two of these patients had variant RHCE genes that encode for weak and partial e antigens and one patient had a partial RHC gene. Frequencies of most RBC antigens were comparable with frequencies established among the African American population; however, K–k– and Jk(a–b–) phenotypes were more frequent and were present in 21% and 17% of patients, respectively.CONCLUSION: The prevalence of RBC alloimmunization in transfused Ghanaian patients with SCD was 6.5% and the majority of antibodies were against antigens of the Rh system. Our findings stress the need to include pretransfusion testing for RBC antibodies in patients with SCD, to improve transfusion safety.
- 6 December 2018
- Published by Wiley in Vox Sanguinis
- Vol. 114 (2) , 162-170
Microchimerism in Ghanaian children recipients of whole blood transfusion for severe anaemia
Background and objectives: Transfusion‐acquired microchimerism (TA‐Mc) has been reported in major trauma but not in young children despite relative immunodeficiency who, in sub‐Saharan Africa, often suffer severe anaemia related to haemoglobinopathies or primary malaria infections. We examined the hypothesis that such massive red cell destructions might provide conditions favourable to TA‐Mc, particularly when exposed to massive amounts of parasite antigens.Materials and Methods: Twenty‐seven female children 6 months post‐transfusion. Four whole blood samples from paediatric females transfused with blood from female donors and five secondary school female students never pregnant, never transfused were used as negative controls.Results: Nineteen patients (70%) carried male Mc with four (15%) having high levels of Mc (>100 genome equivalent of male cells/million of host cells) compared to three controls (37·5%). There was no difference in frequency or quantity of male Mc between paediatric patients with severe malaria and paediatric patients with other causes of severe anaemia. TA‐Mc was not correlated with patient age, duration of whole blood storage or lymphocyte load transfused. After a median of 7 months post‐transfusion, acute malaria did not increase the frequency of TA‐Mc. One negative control appeared to carry low‐level male cells.Conclusion: Transfusion‐acquired microchimerism appears frequent in young children transfused with whole blood for severe anaemia.
- 6 December 2018
- Published by Wiley in Vox Sanguinis
- Vol. 114 (2) , 162-170
Microchimerism in Ghanaian children recipients of whole blood transfusion for severe anaemia
Background and objectives: Transfusion‐acquired microchimerism (TA‐Mc) has been reported in major trauma but not in young children despite relative immunodeficiency who, in sub‐Saharan Africa, often suffer severe anaemia related to haemoglobinopathies or primary malaria infections. We examined the hypothesis that such massive red cell destructions might provide conditions favourable to TA‐Mc, particularly when exposed to massive amounts of parasite antigens.Materials and Methods: Twenty‐seven female children 6 months post‐transfusion. Four whole blood samples from paediatric females transfused with blood from female donors and five secondary school female students never pregnant, never transfused were used as negative controls.Results: Nineteen patients (70%) carried male Mc with four (15%) having high levels of Mc (>100 genome equivalent of male cells/million of host cells) compared to three controls (37·5%). There was no difference in frequency or quantity of male Mc between paediatric patients with severe malaria and paediatric patients with other causes of severe anaemia. TA‐Mc was not correlated with patient age, duration of whole blood storage or lymphocyte load transfused. After a median of 7 months post‐transfusion, acute malaria did not increase the frequency of TA‐Mc. One negative control appeared to carry low‐level male cells.Conclusion: Transfusion‐acquired microchimerism appears frequent in young children transfused with whole blood for severe anaemia.
- Open Access
Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana
Introduction Sickle cell disease is highly prevalent in Africa with a significant public health burden. Nonetheless, morbidity and mortality in sickle cell disease that result from the progression of organ damage is not well understood. The Organ Damage in Sickle Cell Disease Study (ORDISS) is designed as a longitudinal cohort study to provide critical insight into cellular and molecular pathogenesis of chronic organ damage for the development of future innovative treatment. Methods and analysis ORDISS aims to recruit children aged 0–15 years who attend the Kumasi Centre for Sickle Cell Disease based at the Komfo Anokye Teaching Hospital in Kumasi, Ghana. Consent is obtained to collect blood and urine samples from the children during specified clinic visits and hospitalisations for acute events, to identify candidate and genetic markers of specific organ dysfunction and end-organ damage, over a 3 year period. In addition, data concerning clinical history and complications associated with sickle cell disease are collected. Samples are stored in biorepositories and analysed at the Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana and the Centre for Translational and International Haematology, University of Pittsburgh, USA. Appropriate statistical analyses will be performed on the data acquired. Ethics and dissemination Research ethics approval was obtained at all participating sites. Results of the study will be submitted for publication in peer-reviewed journals, and the key findings presented at national and international conferences.
Open AccessOrgan damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana
Introduction Sickle cell disease is highly prevalent in Africa with a significant public health burden. Nonetheless, morbidity and mortality in sickle cell disease that result from the progression of organ damage is not well understood. The Organ Damage in Sickle Cell Disease Study (ORDISS) is designed as a longitudinal cohort study to provide critical insight into cellular and molecular pathogenesis of chronic organ damage for the development of future innovative treatment. Methods and analysis ORDISS aims to recruit children aged 0–15 years who attend the Kumasi Centre for Sickle Cell Disease based at the Komfo Anokye Teaching Hospital in Kumasi, Ghana. Consent is obtained to collect blood and urine samples from the children during specified clinic visits and hospitalisations for acute events, to identify candidate and genetic markers of specific organ dysfunction and end-organ damage, over a 3 year period. In addition, data concerning clinical history and complications associated with sickle cell disease are collected. Samples are stored in biorepositories and analysed at the Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana and the Centre for Translational and International Haematology, University of Pittsburgh, USA. Appropriate statistical analyses will be performed on the data acquired. Ethics and dissemination Research ethics approval was obtained at all participating sites. Results of the study will be submitted for publication in peer-reviewed journals, and the key findings presented at national and international conferences.
- 20 May 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (15_suppl) , e21007
Hodgkins lymphoma: Clinicopathologic features in paediatric patients presenting at the Komfo Anokye Teaching Hospital-Kumasi.
E21007 Background: Hodgkin lymphoma (HL) is a distinct primary solid tumour of the immune system with varied histopathologic subtypes. The epidemiology of HL suggests an infectious etiology with Epstein Barr Virus (EBV) in up to 40% of cases and this association is believed to be causal. HL is the fourth commonest cancer seen amongst the paediatric population in the Paediatric Oncology Unit of the Komfo Anokye Teaching Hospital (KATH) but no data exists about it in our environment. The purpose of this study therefore, is to review the demographic profile of paediatric patients with HL, the proportion of patients with B symptoms, histopathologic subtypes, anatomical nodal sites of involvement and stage at presentation. Methods: This is a retrospective study which reviewed the clinical and histopathological features of Hodgkin’s Lymphoma in paediatric patients at Komfo Anokye Teaching Hospital from January 2010 to December, 2014. Results: A total of 14 patient records were reviewed with male: female ratio o...
- 20 May 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (15_suppl) , e21007
Hodgkins lymphoma: Clinicopathologic features in paediatric patients presenting at the Komfo Anokye Teaching Hospital-Kumasi.
E21007 Background: Hodgkin lymphoma (HL) is a distinct primary solid tumour of the immune system with varied histopathologic subtypes. The epidemiology of HL suggests an infectious etiology with Epstein Barr Virus (EBV) in up to 40% of cases and this association is believed to be causal. HL is the fourth commonest cancer seen amongst the paediatric population in the Paediatric Oncology Unit of the Komfo Anokye Teaching Hospital (KATH) but no data exists about it in our environment. The purpose of this study therefore, is to review the demographic profile of paediatric patients with HL, the proportion of patients with B symptoms, histopathologic subtypes, anatomical nodal sites of involvement and stage at presentation. Methods: This is a retrospective study which reviewed the clinical and histopathological features of Hodgkin’s Lymphoma in paediatric patients at Komfo Anokye Teaching Hospital from January 2010 to December, 2014. Results: A total of 14 patient records were reviewed with male: female ratio o...
- 20 May 2014
- Published by Wiley in Transfusion
- Vol. 54 (11) , 2852-2862
Fourteen‐year experience of a tertiary hospital transfusion committee in West Africa
Background: Hospital transfusion committees (HTCs) have been established in the United States to link producers and users as well as to ensure appropriate use of blood. The HTC has been little reported in sub‐Saharan Africa (SSA), although it has been established in some hospitals.Study Design and Methods: The minutes of three to four HTC meetings per year in a tertiary hospital hosting its own blood service have been reviewed to examine the HTC role over a period of 14 years. Minutes were broken down into themes and indexes, and incomplete data were reinforced by other information sources. Specific data on progress over time were reviewed.Results: The HTC systematically scrutinized the blood supply, blood safety, donor care, clinical use of blood products, and costs. It operated more as a blood transfusion service supervisory board than the limited function allocated to western HTCs. Clinicians and hospital administration were directly involved in decision making and directing investigations to support potential changes and advances in the role and function of the blood transfusion service. The close relation with a UK major blood center and university laboratory provided the impetus and support for research and investigations preliminary to decision making. Data collected and analyzed were reported in the international literature and contributed to disseminate progress made.Conclusions: The HTC in a major SSA tertiary hospital inclusive of all sections of hospital organization was critically instrumental in decision making, funding, and implementing measures improving the amount and quality of blood products on the basis of evidence collected despite lack of resources. Steps are taken to ensure sustainability of the HTC.
- 20 May 2014
- Published by Wiley in Transfusion
- Vol. 54 (11) , 2852-2862
Fourteen‐year experience of a tertiary hospital transfusion committee in West Africa
Background: Hospital transfusion committees (HTCs) have been established in the United States to link producers and users as well as to ensure appropriate use of blood. The HTC has been little reported in sub‐Saharan Africa (SSA), although it has been established in some hospitals.Study Design and Methods: The minutes of three to four HTC meetings per year in a tertiary hospital hosting its own blood service have been reviewed to examine the HTC role over a period of 14 years. Minutes were broken down into themes and indexes, and incomplete data were reinforced by other information sources. Specific data on progress over time were reviewed.Results: The HTC systematically scrutinized the blood supply, blood safety, donor care, clinical use of blood products, and costs. It operated more as a blood transfusion service supervisory board than the limited function allocated to western HTCs. Clinicians and hospital administration were directly involved in decision making and directing investigations to support potential changes and advances in the role and function of the blood transfusion service. The close relation with a UK major blood center and university laboratory provided the impetus and support for research and investigations preliminary to decision making. Data collected and analyzed were reported in the international literature and contributed to disseminate progress made.Conclusions: The HTC in a major SSA tertiary hospital inclusive of all sections of hospital organization was critically instrumental in decision making, funding, and implementing measures improving the amount and quality of blood products on the basis of evidence collected despite lack of resources. Steps are taken to ensure sustainability of the HTC.
- 1 January 2014
- Published by Sciknow Publications in Journal of Internal Medicine Research
- Vol. 2 (2) , 15
The Diagnostic Implications of Spot Urinalysis of Subjects from a Ghanaian Sickle Cell Clinic
- 1 January 2014
- Published by Sciknow Publications in Journal of Internal Medicine Research
- Vol. 2 (2) , 15
The Diagnostic Implications of Spot Urinalysis of Subjects from a Ghanaian Sickle Cell Clinic
- Open Access
- 1 January 2013
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 5 (1) , e2013062
Sickle Cell Disease: Management options and challenges in developing countries
Sickle Cell Disease (SCD) is the most common genetic disorder of haemoglobin in sub-Saharan Africa. This commentary focuses on the management options available and the challenges that health care professionals in developing countries face in caring for patients with SCD. In developing countries like Ghana, newborn screening is now being implemented on a national scale. Common and important morbidities associated with SCD are vaso-occlusive episodes, infections, Acute Chest Syndrome (ACS), Stroke and hip necrosis. Approaches to the management of these morbidities are far advanced in the developed countries. The differences in setting and resource limitations in developing countries bring challenges that have a major influence in management options in developing countries. Obviously clinicians in developing countries face challenges in managing SCD patients. However understanding the disease, its progression, and instituting the appropriate preventive methods are paramount in its management. Emphasis should be placed on newborn screening, anti-microbial prophylaxis, vaccination against infections, and training of healthcare workers, patients and caregivers. These interventions are affordable in developing countries.
- 1 January 2013
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 5 (1) , e2013062
Open AccessSickle Cell Disease: Management options and challenges in developing countries
Sickle Cell Disease (SCD) is the most common genetic disorder of haemoglobin in sub-Saharan Africa. This commentary focuses on the management options available and the challenges that health care professionals in developing countries face in caring for patients with SCD. In developing countries like Ghana, newborn screening is now being implemented on a national scale. Common and important morbidities associated with SCD are vaso-occlusive episodes, infections, Acute Chest Syndrome (ACS), Stroke and hip necrosis. Approaches to the management of these morbidities are far advanced in the developed countries. The differences in setting and resource limitations in developing countries bring challenges that have a major influence in management options in developing countries. Obviously clinicians in developing countries face challenges in managing SCD patients. However understanding the disease, its progression, and instituting the appropriate preventive methods are paramount in its management. Emphasis should be placed on newborn screening, anti-microbial prophylaxis, vaccination against infections, and training of healthcare workers, patients and caregivers. These interventions are affordable in developing countries.
- 1 October 2011
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (10) , 731-736
Prognostic significance of biochemical markers in African Burkitt’s lymphoma
- 1 October 2011
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (10) , 731-736
Prognostic significance of biochemical markers in African Burkitt’s lymphoma